Search studies using keywords
1,851 Studies in the database containing data with -log p ≥ 0 (showing 101-120)
Pages: 1 2 3 4 5 6 7 8 9 10 >>
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST1745 plus GWAS of Lipid traits 
  • Lipid traits (HDL-C)
  • Lipid traits (TG)
  • Lipid traits (TC)
  • Lipid traits (LDL-C)
6
HGVST1746 plus GWAS of Calcium levels 
  • Calcium levels
13
HGVST1747 plus GWAS of Blood pressure 
  • Blood pressure (SBP)
  • Blood pressure (DBP)
11
HGVST1748 plus GWAS of Myopia (severe) 
  • Myopia (severe)
2
HGVST1749 plus GWAS of Systolic blood pressure in sickle cell anemia 
  • Systolic blood pressure in sickle cell anemia
10
HGVST1750 plus GWAS of Otitis media (chronic/recurrent) 
  • Otitis media (chronic/recurrent)
1
HGVST1751 plus GWAS of Borderline personality disorder features 
  • Borderline personality disorder features
1
HGVST1752 plus GWAS of Acute lymphoblastic leukemia (B-cell precursor) 
  • Acute lymphoblastic leukemia (B-cell precursor)
6
HGVST1753 plus GWAS of Rheumatoid arthritis 
  • Rheumatoid arthritis
8
HGVST1740 plus GWAS of IgE levels in asthmatics 
  • IgE levels in asthmatics
  • IgE levels in asthmatics (D.f. specific)
  • IgE levels in asthmatics (D.p. specific)
9
HGVST1741 plus GWAS of Relative hand skill 
  • Relative hand skill in reading disability
  • Relative hand skill
13
HGVST1742 plus GWAS of Adverse response to chemotherapy in breast cancer (alopecia) 
  • Adverse response to chemotherapy in breast cancer (alopecia) (Allelic)
  • Adverse response to chemotherapy in breast cancer (alopecia) (Recessive)
  • Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel) (Allelic)
  • Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel) (Dominant)
  • Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule) (Recessive)
  • Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) (Dominant)
  • Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel) (Allelic)
  • Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel) (Dominant)
  • Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule) (Dominant)
  • Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) (Allelic)
  • Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) (Dominant)
  • Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) (Recessive)
  • Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule) (Allelic)
30
HGVST1743 plus GWAS of Sjogren's syndrome 
  • Sjogren's syndrome
5
HGVST1738 plus GWAS of Crohn's disease 
  • Crohn's disease
8
HGVST1739 plus GWAS of Bronchopulmonary dysplasia 
  • Bronchopulmonary dysplasia (Hispanic)
  • Bronchopulmonary dysplasia
  • Bronchopulmonary dysplasia (Dominant model)
  • Bronchopulmonary dysplasia (AA)
  • Bronchopulmonary dysplasia (EA)
26
HGVST1725 plus GWAS of Alcohol consumption 
  • Alcohol consumption
15
HGVST1726 plus GWAS of Allergic sensitization 
  • Allergic sensitization
12
HGVST1727 plus GWAS of Coronary artery calcification 
  • Coronary artery calcification (AA)
45
HGVST1728 plus GWAS of Atopic dermatitis 
  • Atopic dermatitis
4
HGVST1729 plus GWAS of Homocysteine levels 
  • Homocysteine levels
18